Helius Therapeutics
Latest news of Helius Therapeutics. Based in Auckland, New Zealand, Helius Therapeutics has grown into one of the country’s largest and most advanced cannabis medicines producers.
-
Helius launches first ‘NZ grown, NZ made’ THC medicines
Two new medicinal cannabis products containing THC have been verified as meeting the quality standard. New Zealand’s Medicinal Cannabis Agency publicly advised of the verification on 21 December 2022. This follows Helius, a week earlier, being the first New Zealand company to receive GMP certification to produce THC extracts and…
Read More » -
Helius first to gain THC certification in NZ
Helius Therapeutics will soon launch THC containing medicines which are both grown and made in New Zealand. This follows the country’s largest licenced medicinal cannabis company being issued a GMP (Good Manufacturing Practice) certificate by MedSafe to allow it to manufacture THC medicines. “2022 has been a huge year for…
Read More » -
NZ’s Helius gains certification key to export success
Helius Therapeutics has received Good Agricultural and Collection Practice (GACP) certification at its purpose-built medicinal cannabis facility in East Tamaki, Auckland. Recognised globally, GACP is a leading certification standard for medicinal cannabis. It outlines minimum requirements for growers in creating high quality, consistent flower. “Achieving GACP is another key milestone for…
Read More » -
Verification news brings 100% Kiwi cannabis medicines closer
Helius Therapeutics is the first medicinal cannabis company to have an active ingredient made from locally grown cannabis plants and extracted in New Zealand verified by the Medicinal Cannabis Agency as meeting the quality standard. “This is another first for Helius and a significant milestone for our industry. Wholly New…
Read More » -
NZ medicinal cannabis sector deserves celebration not criticism
The latest Ministry of Health data on medicinal cannabis uptake paints a positive picture. This comes despite ongoing criticism on the availability of local products, price, and doctors’ willingness to prescribe. Yes, challenges around access continue, but New Zealand’s newest industry is making good strides. Let’s not forget Parliament only…
Read More » -
Cannabis collab will see NZ deliver world-first medicines
New Zealand’s largest medicinal cannabis company, Helius Therapeutics, has announced a collaboration with Greenlab – the country’s most experienced biotechnology company in medicinal cannabis genetic development and breeding programmes. The joint research programme aims to further unlock the potential of medicinal cannabis. It will expand Helius’ genetics library, enabling the…
Read More » -
Opposition leader tours NZ medicinal cannabis company, Helius
MP for Botany, Christopher Luxon, has visited local medicinal cannabis company, Helius Therapeutics, where he viewed production of the first New Zealand grown and made full-spectrum products, due to be launched in the second half of this year. “Mr Luxon’s visit to New Zealand’s newest industry was well received. During…
Read More » -
Delivery mode: NZ’s Helius Therapeutics names new CCO
Julie Curphey has been appointed Chief Commercial Officer (CCO) at Helius Therapeutics – New Zealand’s largest licenced medicinal cannabis company. Prior to taking up the role on 1 May, she spent two months as Helius’ Director of Commercial Operations. “Announcing Julie as our CCO reaffirms that Helius has a globally experienced team that’s busy getting…
Read More » -
New licence – great news for Kiwi cannabis patients
“The industry’s first licence renewal and expansion will enable Helius to produce New Zealand grown and made medicinal cannabis products – something Kiwi patients have been waiting for since the inception of the Medicinal Cannabis Scheme. It’s an exciting milestone,” says Carmen Doran, chief executive of Helius Therapeutics. Helius was…
Read More » -
NZ engineers to drive better outcomes for cannabis patients
New Zealand’s largest medicinal cannabis company, Helius Therapeutics, has launched an industry collaboration with the University of Canterbury’s Engineering Faculty. It sees Helius working together over the coming months with Biomedical, Mechanical, and Mechatronics Engineering students supervised by Distinguished Professor Geoff Chase. The final-year student project centres around how accurately the…
Read More »